CoChat

The evaluation of the HIV/AIDS Drug Access Initiatives in Côte DʼIvoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa

Katzenstein, David, Laga, Marie, Moatti, Jean-Paul · 2003 · AIDS
Cited by 82

The DOI matches its Crossref record.

Abstract

Introduction Effective antiretroviral treatment of AIDS in resource-limited settings, particularly sub-Saharan Africa, has become a bellwether issue for patients, physicians and policy-makers. The immense tragedy and enormous challenge of global AIDS raises fundamental questions in ethics and human rights accompanied by key logistic and technical issues in medicine, immunology, virology, public health, macroeconomics and social development. The successes of science and public health interventions in wealthy nations must be translated into a sustainable response for the 90% of people with HIV and AIDS in resource-limited settings. In the first two decades of the HIV epidemic, the parallel efforts of activists, scientists and clinicians resulted in a largely successful paradigm that included prevention of HIV infection and treatment of AIDS. In resource-rich countries these two key modalities reduced the growth of the epidemic and mortality, morbidity and health care costs, the latter most dramatically in the late 1990s with widespread (although not universal) access to highly active antiretroviral therapy (HAART). By contrast, for the vast majority of HIV-infected people that live in sub-Saharan Africa, surveillance, education and information and (potential) vaccines strategies were thought to be the only possible modalities to combat the epidemic. Although the efficacy of antiretroviral therapy was evident from results presented at the 11th World Aids Conference in 1996 in Vancouver, access to antiretroviral treatment (ART) was not considered feasible in developing countries by most experts in the field [1–3]. Despite the powerful reluctance to introduce ART in the South, various non-governmental organizations (NGOs) and some governments of developing countries moved quickly to address access to effective treatments for HIV infection. Responding to their demands, the UNAIDS secretariat launched the so-called Drug Access Initiative (DAI) in November 1997. The DAI was designed to explore the feasibility of a ‘structured introduction of price-reduced ARV therapy’ and of a ‘rational and affordable use’ of ART ‘in a range of developing countries’. Participants in an initial phase of the DAI were Chile, Côte d'Ivoire, Uganda and Vietnam. In these countries, the explicit goal of the DAI was to set up the necessary infrastructure and systems to increase access to HIV-related drugs ‘on a small but sustainable scale’ [4]. In sub-Saharan Africa, the projects respectively started in June 1998 in Côte d'Ivoire, with a population of almost 13 million and over 800 000 people infected with HIV, and in August 1998 in Uganda, with 21 million people of whom 1 million were estimated to be living with HIV/AIDS. In parallel, building upon a successful national prevention campaign, and with an HIV prevalence of less than 2% among adults, the Senegalese government introduced its own pilot Initiative for Access to Antiretroviral Drugs (ISAARV) in 1998. In the context of global scepticism, very real economic and political barriers surrounded even small-scale programs for access to ART in developing countries. Thus, UNAIDS and the Ministries of Health of Côte d'Ivoire, Senegal and Uganda developed programs to carefully evaluate these first experiences of organized ARV delivery in Africa. Independent teams of researchers conducted evaluations of these HIV Drug Access Initiatives between 1998 and 2002, benefiting from the technical assistance of the French Agency for AIDS Research (ANRS) in Senegal, of the Centers of Disease Control and Prevention (CDC) in Uganda, and of both agencies in Côte d'Ivoire. During this 5-year period, the attention of the world and the public health community has become progressively more focused on drug access and equity in HIV treatment [5–7]. The International AIDS Society (IAS) meetings ‘Bridging the Gap’ in Geneva in 1998, and ‘Breaking the Silence’ in Durban in 2000, emphasized the growing inequity in access to care and treatment. These events led to the United Nations General Assembly Special Session on AIDS in 2001, culminating in the establishment of a multi-lateral Global Fund to Fight AIDS, Tuberculosis and Malaria at the beginning of 2002. While it is currently estimated that 4 million people are in immediate medical need of ART in sub-Saharan Africa alone, the goal of scaling up access to ART is increasingly shared by governments and international donor organizations. A recent analysis of the national HIV/AIDS plans of 90 developing countries conducted by WHO indicates that about 60% of these countries have now either incorporated ART into their national strategies to fight the epidemic or have defined specific ART coverage targets [8]. In July 2002 at the 14th International AIDS Conference in Barcelona, WHO and other UN organizations committed themselves to the goal of expanding access to ART to 3 million people in the developing world by 2005 [9]. For this special edition of AIDS, the investig

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00002030-200317003-00001

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 82

Metadata

Authors
Katzenstein, D., Laga, M., & Moatti, J.-P.
Venue
AIDS
Published
2003-07
Volume
17
Pages
S1-S4
ISSN
0269-9370 (ISSN-L)
OpenAlex
W2044252782
Cited by
82
References
0
FWCI
6.12
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The evaluation of the HIV/AIDS Drug Access Initiatives in Côte DʼIvoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa. https://app.cochat.ai/papers/10.1097/00002030-200317003-00001
The paper
Katzenstein, D., Laga, M., & Moatti, J.-P. (2003). The evaluation of the HIV/AIDS Drug Access Initiatives in Côte DʼIvoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa. AIDS. https://doi.org/10.1097/00002030-200317003-00001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.